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Summary 
123
Postpartum anestrous interval in beef cows is a 
major factor contributing to reproductive failure 
during a defined breeding season. Our 
objectives were to determine the ability of a 
controlled internal drug-releasing device (CIDR), 
or melengestrol acetate (MGA) to induce 
ovulation and to eliminate short estrous cycles. 
Multiparous beef cows (n = 75) were equally 
assigned by age, days postpartum, body 
condition, and body weight to one of three 
treatments: CIDR, MGA, or control.  All cows 
were fed carrier (2 lbs•cow-1•day-1) with MGA 
(0.25 mg/lb) or without MGA for 7 days (day -6 
to 0).  On day -6, CIDR were inserted and were 
removed on d 0.  Estrous behavior was 
monitored continuously from day -6 until 29 
using HeatWatch electronic mount detectors.  
Blood was collected three times weekly from day 
-6 to 29.  Treatment influenced (P = 0.03) the 
percentage of cows that were detected in 
standing estrus. Beginning on d 2, more CIDR-
treated cows had exhibited standing estrus 
compared to control cows, but CIDR- and MGA-
treated cows did not differ. The percentage of 
CIDR-treated cows that had ovulated was 
greater (P < 0.05) than the percentage of MGA-, 
or control-treated cows beginning on day 4.  The 
percentage of cows that exhibited standing 
estrus before the first postpartum ovulation 
(CIDR = 65%, MGA = 57%, control = 30%) did 
not differ (P = 0.09) among treatments.  Luteal 
lifespan following the first ovulation postpartum 
and the percentage of cows with a normal luteal 
lifespan (progesterone > 1 ng/mL for ≥ 10 d) was 
greater (P < 0.01) in CIDR-treated cows (14.0 ± 
0.8 days; 20/20, 100%) compared with MGA- 
(6.2 ± 1.0 days; 3/13, 23%), or control-treated 
cows (6.1 ± 0.9 days; 4/17, 24%). In the present 
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study, treatment of early postpartum suckled 
beef cows with CIDR-induced ovulation and 
initiated estrous cycles with a normal luteal 
lifespan in more cows than treatment with MGA, 
and treatment with MGA did not induce ovulation 
earlier than control cows. 
 
Introduction 
 
The anestrous postpartum interval is a major 
contributing factor to cows failing to become 
pregnant and calving on a yearly interval.  In 
addition, a short luteal phase can further delay 
the interval from calving to conception and 
usually occurs following the first postpartum 
ovulation.  Treatment with some progestins can 
induce ovulation in postpartum anestrous cows, 
shortening the anestrous postpartum interval 
(Yavas and Walton, 2000; Lucy et al., 2001), 
and treatment with some progestins before the 
first postpartum ovulation reduced or eliminated 
the occurrence of a short luteal phase (Smith et 
al., 1987; Zollers et al., 1989).  Therefore, many 
estrous synchronization protocols have included 
progestin treatment; however, all progestins do 
not have the same biological response.  More 
specifically, 46% of anestrous beef cows fed 
melengestrol acetate (MGA), an orally active 
progestin, before GnRH-induced ovulation had a 
normal luteal phase, compared with 100% of 
cows exposed to progesterone for the same 
time period (Smith et al., 1987).  Because 
different progestins have been used 
interchangeably in estrous synchronization 
protocols, the objectives of the present study 
were to determine the ability of progesterone or 
MGA to induce ovulation in postpartum 
anestrous beef cows, and to determine the 
ability of each to decrease or eliminate the 
occurrence of a short luteal phase following 
ovulation. 
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Materials and Methods 
 
Experimental Design.  Postpartum multiparous 
(n = 75) crossbred beef cows at the Fort Keogh 
Livestock and Range Research Laboratory were 
divided equally into three treatment groups 
[MGA (0.5 mg•cow-1•day-1), controlled internal 
drug-releasing device (CIDR; 1.9 g of 
progesterone; InterAG, Hamilton, NZ), and 
control] according to age (range 4 to 11 yr), days 
postpartum (range 9 to 45 days), cow body 
condition score (1 = emaciated and 9 = obese;  
range 4 to 6.5), and post calving body weight 
(range 445 to 704 kg).  Calves were maintained 
with cows at all times and allowed to suckle 
without restriction.  Cows that had initiated 
estrous cycles before the start of treatment were 
removed from the study (MGA = 7; CIDR = 3; 
control = 3).  In addition, one animal in the MGA 
group ovulated during MGA treatment and was 
removed from the study, but animals that 
exhibited standing estrus but did not ovulate 
were left in their respective treatment. 
 
Cows were fed carrier (wheat middlings pellets, 
United Agri Products, Miles City, MT) 2 lbs•cow-
1•d-1 with MGA (0.25 mg/lb) or without MGA for 
7 days (day -6 through day 0).  Controlled 
internal drug-releasing devices (1.9 g 
progesterone per device) were inserted into the 
vagina of cows on the first day of treatment (day 
-6) and were removed on day 0.  All cows were 
individually fitted with estrous detection 
transmitters and monitored for estrous behavior 
continuously from day -6 until day 29 with the 
HeatWatch Estrous Detection System (DDx, 
Inc., Denver, CO).  Cows were considered to be 
in standing estrus when three mounts of 2 
seconds or longer in duration were recorded 
within a 4-hour period. 
 
Blood samples were collected via puncture of a 
tail vessel three times weekly for determination 
of concentrations of progesterone.  Blood was 
allowed to clot, stored a 4°C for 24 hours, 
centrifuged at 2000 x g for 30 minutes and 
serum collected.  Serum was stored at -20°C 
untilled assayed for progesterone. 
 
Statistical Analysis.  Luteal lifespan was 
analyzed for an effect of treatment by ANOVA 
using SAS (proc GLM; SAS Inst. Inc., Cary, NC).  
When the F statistic was significant (P < 0.05), a 
mean separation was performed using the least 
significant difference test.  The percentage of 
cows exhibiting estrus before an increase in 
progesterone and the percentage of cows with a 
normal length luteal lifespan (progesterone > 1 
ng/mL for ≥ 10 days) were analyzed for and 
effect of treatment using categorical data 
modeling in SAS (Proc Catmod).  To determine 
differences in the distribution of the response to 
the different treatments, the percentage of 
animals detected in standing estrus, and the 
percentage of animals with elevated 
progesterone (> 1 ng/mL) were analyzed for an 
effect of treatment, day, and treatment by day 
interaction using analysis of repeated measures 
of categorical data.   
 
Results and Discussion 
 
There were no significant differences among 
treatments in days postpartum, body condition 
score, or weight at the initiation of treatment 
(Table 1).  A greater (P < 0.05) percentage of 
CIDR-treated cows had exhibited standing 
estrus on day 2 after treatment withdrawal 
compared with control-treated cows, but 
beginning on day 14 no significant difference 
was detected between CIDR- and control-
treated cows.  There was a tendency (P = 0.07), 
from day 4 through 10, for the percentage of 
CIDR-treated cows that had exhibited estrus to 
be greater than the percentage of MGA-treated 
cows that had exhibited estrus.  The percentage 
of MGA- and control-treated cows that exhibited 
standing estrus did not differ on any day of the 
experiment. 
 
Peripubertal beef heifers treated with MGA for 8 
days, increased proportion of heifers that 
initiated estrous cycles following treatment 
withdrawal compared with untreated controls 
(Imwalle et al., 1998).  In contrast, when 
postpartum anestrous beef cows were treated 
with MGA for 14 days only 13% ovulated within 
7 days of treatment withdrawal (2/16, Perry et 
al., 2002).  In the present study, ovulation was 
defined as occurring 4 days before circulating 
concentrations of progesterone were greater 
than 1 ng/mL.  The percentage of CIDR-treated 
cows that ovulated was greater (P < 0.05) than 
the percentage of MGA-, or control-treated cows 
that ovulated beginning on day 4 after treatment 
withdrawal.  On day 18, the cumulative 
percentage of CIDR- and control-treated cows 
that had ovulated did not differ (P = 0.08), and 
no difference was detected between CIDR-
treated cows and MGA- (P = 0.19) treated (P = 
0.58) cows on day 22 (Figure 2).  The 
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percentage of cows that ovulated was not 
different between control- and MGA-treated 
cows on any day of the experiment (Figure 2).   
 
Differences in the response of early postpartum 
anestrous beef cows to different progestins may 
be explained by the ability of progestins to 
increase LH pulse frequency and cause the 
formation of a persistent follicle.  When early 
postpartum anestrous non-suckled (Williams et 
al., 1983) and anestrous suckled (Garcia-Winder 
et al., 1986) beef cows were treated with low 
doses of a progestin LH pulse frequency 
increased compared to non-treated controls.  In 
addition, exposure of peripubertal heifers to a 
low dose of norgestomet increased LH pulse 
frequency, stimulated follicular development, 
and resulted in formation and ovulation of 
persistent follicles (Anderson et al., 1996).  
Treatment of peripubertal heifers with MGA (0.5 
mg•cow-1•d-1) for 7 days increased LH pulse 
frequency following treatment withdrawal 
(Imwalle et al., 1998), but feeding MGA (0.5 
mg•cow-1•d-1) for 14 days to early postpartum 
anestrous beef cows did not result in formation 
of persistent follicles (Perry et al., 2002).  In 
contrast, treatment of early postpartum 
anestrous dairy cows with low concentrations of 
progesterone (CIDR) resulted in increased LH 
pulse frequency compared with untreated 
controls (Rhodes et al., 1997). 
 
A more synchronous rise in concentration of 
progesterone occurred following treatment in 
CIDR-treated cows compared with other 
treatments (Figure 3).  However, no difference 
(P = 0.32) was detected among treatments in 
the percentage of cows that exhibited standing 
estrus before an increase in progesterone (65%, 
57%, and 30% for CIDR, MGA, and control, 
respectively). 
 
Progesterone treatment is necessary for 
establishment of the normal timing of uterine 
PGF2α secretion.  In the present study, only 
cows that had progesterone > 1 ng/mL were 
used to determine luteal lifespan and the 
percentage of cows with a normal length luteal 
lifespan (progesterone > 1 ng/mL for ≥ 10 days).  
Following the first ovulation postpartum, CIDR-
treated cows had a longer luteal lifespan than 
MGA- or control-treated cows (Table 2), and the 
percentage of cows that had a normal length 
luteal phase (≥ 10 days) was greater (P < 0.01) 
in CIDR-treated cows than in MGA- or control-
treated cows (Table 2).   
 
Treatment-induced ovulation was defined as 
ovulation occurring within 5 days of treatment 
withdrawal (increase in concentration of 
progesterone > 1 ng/mL on days 5 to 10) for 
CIDR- and MGA-treated cows and all ovulations 
in control treated cows.  Following treatment-
induced ovulation, a longer luteal lifespan (P < 
0.01) was detected in CIDR-treated cows than in 
MGA- or control-treated cows (Table 2).  The 
percentage of cows with a normal (≥ 10 d) luteal 
lifespan following treatment-induced ovulation 
was greater (P < 0.01) in CIDR-treated cows 
than MGA- or control-treated cows.  This is 
consistent with previous reports in which 
treatment of anestrous postpartum beef cows 
with 0.5 mg•cow-1•d-1 of MGA for 5 days before 
GnRH-induced ovulation resulted in only 46% of 
cows having a normal luteal phase, but 
treatment with progesterone for 5 days before 
GnRH-induced ovulation resulted in 100% of 
cows having a normal luteal phase (Smith et al., 
1987).  Thus, the normal dose of MGA (0.5 
mg•cow-1•d-1) is not adequate to prevent the 
earlier secretion of uterine PGF2α following the 
first postpartum ovulation. 
 
Implications 
 
The anestrous postpartum period and the 
occurrence of short estrous cycles are major 
factors in cows not conceiving during a defined 
breeding season, and treatment with some 
progestins before the breeding season can 
successfully induced ovulation and eliminated 
the occurrence of short estrous cycles.  
However, in the current study MGA was not as 
effective at inducing ovulation in early 
postpartum anestrous beef cows as CIDR 
treatment.  In addition, treatment with a CIDR 
resulted in a normal luteal lifespan following 
ovulation compared with a short luteal phase in 
cows treated with MGA.  Therefore, not all 
progestins are equally effective at inducing 
ovulation and eliminating short estrous cycles in 
early postpartum anestrous cows. 
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Table 1.  Days postpartum, body condition score, and weight at the initiation of treatment 
 CIDRa MGAb Control 
No. of cows 22 17 22 
Days postpartum (range) 31 ± 1.7 
(12 to 42) 
30 ± 2.0 
(12 to 45) 
30 ± 1.5 
(9 to 39) 
Body condition score 
(range)c
4.9 ± 0.2 
(4 to 6) 
4.9 ± 0.2 
(3.5 to 6.5) 
4.9 ± 0.2 
(3.5 to 6) 
Weight, kg 
(range) 
581 ± 16.4 
(477 to 684) 
583 ± 17.3 
(475 to 704) 
571 ± 16.4 
(445 to 692) 
 
aControlled internal drug–releasing device. 
bMelengestrol acetate (0.5 mg MGA•cow-1•d-1). 
cBody Condition Score – scale 1 to 9 
 
 
 
Table 2.  Effect of treatment on luteal lifespan and percentage of cows with a normal luteal lifespan 
following their first ovulation postpartum and ovulation within 5 days of treatment withdrawal 
 First postpartum ovulation 
 CIDRa MGAb Controld CIDR vs MGA 
CIDR vs 
Control 
MGA vs 
Control 
No. of cows 20 13 17 - - - - - - - - P-value - - - - - - - - 
Luteal lifespan, dayse 14.0 ± 0.8 6.2 ± 1.0 6.1 ± 0.9 < 0.01 < 0.01 = 0.98 
Cows with normal luteal 
lifespan, %f 100 23 24 < 0.01 < 0.01 = 0.97 
       
 Ovulation within 5 days of treatment withdrawal 
 CIDRa MGAb Controlc CIDR vs MGA 
CIDR vs 
Control 
MGA vs 
Control 
No. of cows 20 5 17 - - - - - - - - P-value - - - - - - - - 
Luteal lifespan, daysd 14.0 ± 0.8 4.4 ± 1.1 6.1 ± 0.9 < 0.01 < 0.01 = 0.29 
Cows with normal luteal 
lifespan, %e 100 0 24 < 0.01 < 0.01 = 0.15 
aControlled internal drug–releasing device. 
bMelengestrol acetate (0.5 mg MGA•cow-1•day-1). 
cControl animals 
dInterval from first day of concentrations of progesterone were > 1 ng/mL to day concentrations of 
progesterone decreased to < 1 ng/mL. 
ePercentage of animals with a luteal lifespan (i.e., concentrations of progesterone > 1 ng/mL) of 10 
days or longer. 
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Figure 1.  Effect of treatment on cumulative percentage of cows detected in standing estrus by day of 
treatment (day 0 = last day of feeding melengestrol acetate [MGA], and day of controlled 
internal drug-releasing device [CIDR] removal).  Treatment P = 0.03;  Day P < 0.01;  Treatment 
x Day P < 0.01. 
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Figure 2.  Effect of treatment on the cumulative percent of animals that had ovulated (ovulation is shown 
as having occurred 4 days before the first day circulating concentrations of progesterone were 
> 1 ng/mL) by day of treatment (day 0 = last day of feeding melengestrol acetate [MGA], and 
day of controlled internal drug-releasing device [CIDR] removal).  Treatment P < 0.01;  Day P < 
0.01;  Treatment x Day P < 0.01. 
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Figure 3.  Circulating concentrations of progesterone (collected three times weekly) for cows receiving no 
treatment (control), 0.5 mg MGA•cow-1•day-1 (MGA), or controlled internal drug-releasing 
device (CIDR; from day –6 to 0).  Day 0 = last day of feeding MGA and day of CIDR removal. 
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